| Special Articles | Moringa oleifera Lam - The Miracle tree | Mehnaz kamal | 0 | 1 day 3 hours ago |
| Student Articles | Pharmacovigilance : Indian Scenario | Anonymous | 0 | 3 days 32 min ago |
| Special Articles | Application of Nanobiosensors and Biochips in Health Care : A Review | Murugan Veerapandian | 0 | 3 days 1 hour ago |
| Special Articles | Total Quality Management : A Promising Fixation To Accomplish Zero Defects | tarun.satpathy | 1 | 4 days 3 hours ago |
| Rfeeds | Rasilez® first-in-class direct | raja | 0 | 4 days 4 hours ago |
| Rfeeds | Sandoz receives FDA | raja | 0 | 4 days 9 hours ago |
| Special Articles | Counterfeit Medicines - The Global Hazard | saurabhdahiya | 0 | 6 days 15 sec ago |
| Special Articles | Organic Impurities present in Pharmaceuticals and Food Products | poonmphar | 4 | 6 days 9 hours ago |
| Rfeeds | Novartis decides not to pursue further development of Aurograb(TM) | raja | 0 | 1 week 2 days ago |
| Special Articles | Gelucires : Pharmaceutical Applications | nrjadhav20 | 2 | 1 week 3 days ago |
| Videos | Pharmacist Salary Survey Round Table | raja | 0 | 1 week 3 days ago |
| Special Articles | Osteoarthritis : An Elderly Problem | Anonymous | 2 | 1 week 4 days ago |
| Rfeeds | Glivec receives FDA priority review as first therapy to reduce recurrence of gastrointestinal stromal tumors after surgery | raja | 0 | 1 week 4 days ago |
| Rfeeds | NICE final guidance recommends Lucentis® as cost-effective treatment for wet AMD, a leading cause of blindness | raja | 0 | 1 week 4 days ago |
| Special Articles | Probiotics : An Innovative Globe | Vikash Kumar | 4 | 1 week 5 days ago |
| Special Articles | An Introduction To Analytical Method Development For Pharmaceutical Formulations | Rashmin | 6 | 1 week 5 days ago |
| Videos | Cellcept and Myfortic Linked to Birth Defects and Fetal Loss | Anonymous | 0 | 2 weeks 20 hours ago |
| Rfeeds | Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development announce five-year collaboration targeted to accelerate TB treatment R&D | raja | 0 | 2 weeks 22 hours ago |
| Rfeeds | Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case | raja | 0 | 2 weeks 22 hours ago |
| Rfeeds | Novartis completes acquisition of 25% stake in Alcon from Nestlé, first step toward majority ownership of the world leader in eye care | raja | 0 | 2 weeks 22 hours ago |
| Rfeeds | Novartis buys additional 51.7% stake in Speedel and announces plans to acquire remaining shares in a mandatory public tender offer | raja | 0 | 2 weeks 22 hours ago |
| Rfeeds | Novartis enters strategic partnership with Lonza to accelerate growth of biologics pipeline | raja | 0 | 2 weeks 22 hours ago |
| Rfeeds | Novartis gains momentum with strong performance in first half of 2008 from portfolio focused on growth areas of healthcare | raja | 0 | 2 weeks 22 hours ago |
| Rfeeds | Once-yearly Aclasta® recommended in EU to treat male osteoporosis and reduce risk of new fractures in patients after hip fracture | raja | 0 | 2 weeks 22 hours ago |
| Rfeeds | Exforge® helps nearly twice as many patients control their high blood pressure compared to amlodipine alone | raja | 0 | 2 weeks 22 hours ago |
